JMS CO.,LTD. is a Japan-based company mainly engaged in the manufacture and sale of medical equipment and drugs. The Company operates through five geographical segments including Japan, Singapore, China, Philippines and Germany. The Company is engaged in the manufacture and sale of infusion and nutrition products, dialysis products, surgery products, blood and cell products and other products. The Companyâ€™s main products include infusion & transfusion set, syringe pump, surgical gown, dialysis kit, peritoneal dialysate, microcatheter, blood bag, among others. The Company is also involved in the provision of maintenance service and other related services.

Employees

4,887

Sector

Medical Equipment, Supplies & Distribution

Calendar

09-29 Ex-dividend date - 8.5 JPY

More about the company

Quotes

Date	Price	Change	Volume
26-09-18	JP¥459.00	0.00%	22,300
26-09-17	JP¥459.00	+0.66%	17,700
26-09-16	JP¥456.00	0.00%	13,000
26-09-15	JP¥456.00	+0.88%	14,400
26-09-14	JP¥452.00	-0.22%	16,800

Delayed Quote Japan Exchange

More quotes

Quarterly revenue - Rate of surprise

Company calendar

Market Closed - Japan Exchange 02:30:00 2026-09-18 EDT			5-day change	1st Jan Change
459.00 ^JPY	0.00%		+1.32%	+3.85%

05-12	JMS Co.,Ltd. Provides Consolidated Earnings Guidance for the Half Year Ending September 2026 and the Full Year Ending March 31, 2027	CI
05-12	JMS Co.,Ltd. Proposes Dividend for Fiscal Year Ended March 31, 2026, Payable on June 24, 2026; Provides Dividend Guidance for Second Quarter Ending September 2026 and Fiscal Year Ending March 31, 2027	CI

Market Cap	11.26B 71.73M 62.55M 59.06M 53.63M 100M 6.88B 101M 707M 273M 3.5B 269M 263M	P/E 2025	127x	P/E 2026	-13.3x
Enterprise Value	31.54B 201M 175M 165M 150M 282M 19.28B 283M 1.98B 765M 9.8B 755M 738M	EV / Sales 2025	0.43x	EV / Sales 2026	0.47x
Free-Float	64%	Yield 2025	3.69%	Yield 2026	4%

05-12	JMS Co.,Ltd. Provides Consolidated Earnings Guidance for the Half Year Ending September 2026 and the Full Year Ending March 31, 2027	CI
05-12	JMS Co.,Ltd. Proposes Dividend for Fiscal Year Ended March 31, 2026, Payable on June 24, 2026; Provides Dividend Guidance for Second Quarter Ending September 2026 and Fiscal Year Ending March 31, 2027	CI
02-06	JMS Co.,Ltd. Provides Consolidated Earnings Guidance for the Year Ending March 31, 2026	CI
11-07	JMS Co.,Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2026	CI
11-07	JMS Co.,Ltd. Announces Dividend for the Second Quarter End of the Fiscal Year Ending March 31, 2026, Payable on December 10, 2025	CI
25-05-09	JMS Co.,Ltd. Announces Dividend for the Year Ended March 31, 2025, Payable on June 25, 2025; Provides Dividend Guidance for the Second Quarter and Year Ending March 31, 2026	CI
25-05-09	JMS Co.,Ltd. Provides Earnings Guidance for the Six Months Ending September 2025 and the Full Year Ending March 31, 2026	CI
25-02-07	JMS Co.,Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2025	CI
24-11-07	JMS Co.,Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2025	CI
24-11-07	JMS Co.,Ltd. Announces Dividend for the Second Quarter Period Ended September 2024, Payable on December 10, 2024 and Provides Dividend Guidance for the Year Ending March 31, 2025	CI
24-05-14	JMS Co.,Ltd. Provides Earnings Guidance for the Six Months Ending September 2024 and the Full Year Ending March 31, 2025	CI
24-05-14	Jms Co.,Ltd. Announces Dividend for the Year Ended March 31, 2024, Payable on June 26, 2024; Provides Dividend Guidance for the Second Quarter Ending September 2024 and Year Ending March 31, 2025	CI
23-11-07	JMS Co.,Ltd. Announces Dividend for the Second Quarter ended September 2023 Payable on December 8, 2023; Provides Guidance for the Year End for the Year March 31, 2024	CI

1 week	+1.32%
Current month	-1.92%
1 month	+0.44%
3 months	+3.38%
6 months	+2.68%
Current year	+3.85%

JMS Co.,Ltd. Stock

Stocks

7702

JP3386050003

Medical Equipment, Supplies & Distribution

Valuation: JMS Co.,Ltd.

Chart: JMS Co.,Ltd.

Latest news: JMS Co.,Ltd.

Press Releases: JMS Co.,Ltd.

Quotes and Performance

Price Extremes

Managers and Directors: JMS Co.,Ltd.

Other Medical Equipment, Supplies & Distribution

Financials

Company Profile

Quotes

Quarterly revenue - Rate of surprise

Manager	Title	Age	Since
Ryuji Katsura DFI	Director of Finance/CFO	63	2007-06-30
Raita Uematsu CTO	Chief Tech/Sci/R&D Officer	59	2023-05-31
Toru Sakota PRN	Corporate Officer/Principal	59	2012-03-31

Director	Title	Age	Since
Hiroaki Okukubo CHM	Chairman	70	2024-05-31
Yasuhiro Awane BRD	Director/Board Member	65	2011-05-31
Yoshio Kondo BRD	Director/Board Member	70	2023-05-31

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
JMS CO.,LTD.	0.00%	+1.32%	+1.10%	-16.70%	72.26M
ABBOTT LABORATORIES	+0.37%	+0.65%	-23.75%	+1.59%	177B
MEDTRONIC PLC	-0.69%	+1.29%	-3.62%	+11.27%	119B
CENCORA, INC.	-0.20%	-3.98%	+6.17%	+72.47%	59.04B
BECTON, DICKINSON AND COMPANY	-0.24%	+1.74%	-3.94%	-31.61%	49.41B
HOYA CORPORATION	-0.22%	-0.37%	+7.26%	+35.20%	48.64B
DEXCOM, INC.	+1.61%	+7.61%	+17.91%	-6.24%	33.18B
MEDLINE INC.	-1.49%	-2.74%	-	-	28.18B
WEST PHARMACEUTICAL SERVICES, INC.	-1.17%	+4.64%	+42.09%	-8.18%	25.8B
SARTORIUS STEDIM BIOTECH	+1.02%	+5.99%	+7.20%	-19.54%	21.91B
Average	-0.10%	+1.68%	+5.60%	+4.25%	56.18B
Weighted average by Cap.	-0.08%	+0.88%	-4.25%	+9.75%

	2025	2026
Net sales	69.75B 444M 387M 366M 332M 622M 42.64B 625M 4.38B 1.69B 21.68B 1.67B 1.63B	65.84B 419M 366M 345M 314M 588M 40.25B 590M 4.14B 1.6B 20.46B 1.58B 1.54B
Net income	89M 567K 494K 467K 424K 794K 54.4M 798K 5.59M 2.16M 27.66M 2.13M 2.08M	-783M -4.99M -4.35M -4.11M -3.73M -6.99M -479M -7.02M -49.2M -18.99M -243M -18.74M -18.32M
Net Debt	19.04B 121M 106M 99.87M 90.69M 170M 11.64B 171M 1.2B 462M 5.92B 456M 446M	20.28B 129M 113M 106M 96.62M 181M 12.4B 182M 1.27B 492M 6.3B 485M 475M

1 week	450	460
1 month	448	469
Current year	418	478
1 year	418	478
3 years	405	559
5 years	405	867
10 years	405	1,198